Johan W. de Fijter

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 538 citations

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Bengt Fellström, Jonathan Barratt, H. Terence Cook et al. · The Lancet · 2017 · 386 citations · Full text

Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

Marlies E. J. Reinders, Johan W. de Fijter, Helene Roelofs et al. · Stem Cells Translational Medicine · 2013 · 362 citations · Full text

Delayed graft function influences renal function, but not survival

Henk Boom, Marko J.K. Mallat, Johan W. de Fijter et al. · Kidney International · 2000 · 315 citations

Urology, Kidney Transplant, Medicine +7

The Effect of Tolerance to Noninherited Maternal HLA Antigens on the Survival of Renal Transplants from Sibling Donors

William J. Burlingham, Alan P. Grailer, Dennis M. Heisey et al. · New England Journal of Medicine · 1998 · 275 citations